Table 2.

Results from the myeloablative versus nonmyeloablative HSCT study

Relapse and TRM: Cox
Relapse: CRR
TRM: CRR
VariableβHRPβHRPβHRP
Patient age0.0171.020.560.0491.050.27−0.0300.970.48
Unrelated donor0.0471.050.83−0.1640.850.630.2711.310.35
Bone marrow0.1181.130.71−0.7810.460.110.8082.240.057
Nonmyeloablative−0.4280.650.25−0.5560.570.330.0571.060.90
Unfavorable prognosis0.4261.530.060.8912.440.020.2551.290.38
Second transplant0.2581.290.400.0891.090.830.3051.360.46
aGVHD prophylaxis0.0271.030.940.0801.080.87−0.6470.520.31
Sex mismatch−0.3850.680.053−0.6590.520.040.1791.200.50
  • NOTE: β, parameter estimate for each variable; Cox, Cox proportional hazards model for relapse and TRM combined as a single event; CRR, competing risks regression model using the Fine and Gray method.